MULTIPARAMETRIC TUMOR-MARKER ANALYSES (CA 19-9, CEA, UROKINASE-TYPE ANTIGEN) IN PLASMA OF PATIENTS WITH COLORECTAL-CANCER OR CROHNS-DISEASE

被引：0
|
作者：
HUBER, K
SEDLMAYER, A
KIRCHHEIMER, JC
RIMPFL, T
BINDER, BR
机构：
[1] VIENNA UNIV, DEPT CLIN EXPTL PHYSIOL, A-1090 VIENNA, AUSTRIA
[2] VIENNA UNIV, DEPT CARDIOL, A-1090 VIENNA, AUSTRIA
[3] VIENNA UNIV, DEPT GASTROENTEROL 2, A-1090 VIENNA, AUSTRIA
来源：
BLUT | 1988年 / 57卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [21] Differences in plasma gastrin, CEA, and CA 19-9 concentration in patients with proximal and distal colorectal cancer
    Bombski, G
    Gasiorowska, A
    Orszulak-Michalak, D
    Neneman, B
    Kotynia, J
    Strzelczyk, J
    Janiak, A
    Malecka-Panas, E
    JOURNAL OF GASTROINTESTINAL CANCER, 2002, 31 (1-3) : 155 - 163
  • [22] Differences in plasma gastrin, CEA, and CA 19-9 concentration in patients with proximal and distal colorectal cancer
    Grzegorz Bombski
    Anita Gasiorowska
    Daria Orszulak-Michalak
    Beata Neneman
    Justyna Kotynia
    Janusz Strzelczyk
    Adam Janiak
    Ewa Malecka-Panas
    International Journal of Gastrointestinal Cancer, 2002, 31 : 155 - 163
  • [23] THE RADIOIMMUNOASSAY OF CARBOHYDRATE ANTIGEN 19-9 - COMPARISON WITH CEA AND TPA IN THE FOLLOW-UP OF COLORECTAL-CANCER
    TOMMASI, M
    CAPPELLI, G
    FUCINI, C
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1983, 27 (02): : 201 - 201
  • [24] THE USE OF CEA AND CA 19-9 IN THE FOLLOW-UP AFTER CURATIVE RESECTION OF COLORECTAL-CANCER
    STAPEL, A
    FRANKE, U
    PUTZKI, H
    ZENTRALBLATT FUR CHIRURGIE, 1992, 117 (02): : 77 - 80
  • [25] The Prognostic Value of CEA As a Complementary Tumor Marker of CA 19-9 in Resected Pancreatic Cancer
    Parikh, Dhavan A.
    Azarm, Ali
    Urayama, Shiro
    GASTROENTEROLOGY, 2013, 144 (05) : S659 - S659
  • [26] Prognostic Value of Preoperative CEA and CA 19-9 Levels in Patients with Colorectal Cancer
    Basbug, Murat
    Arikanoglu, Zulfu
    Bulbuller, Nurullah
    Cetinkaya, Ziya
    Aygen, Erhan
    Akbulut, Sami
    Satici, Omer
    HEPATO-GASTROENTEROLOGY, 2011, 58 (106) : 400 - 405
  • [27] Plasma gastrin, CEA and CA 19-9 concentrations differ in patients with proximal and distal colorectal cancer (CRC)
    Gasiorowska, A
    Orszulak-Michalak, D
    Bombski, G
    Kotynia, J
    Strzelczyk, J
    Janiak, A
    Malecka-Panas, EI
    GASTROENTEROLOGY, 2002, 122 (04) : A592 - A592
  • [28] APPEARANCE OF THE TUMOR-MARKER CA 19-9 IN LIVER-TRANSPLANT PATIENTS DURING REJECTION EPISODES
    SAMESHIMA, Y
    CHIA, D
    TERASAKI, PI
    IMAGAWA, DK
    BUSUTTIL, RW
    TRANSPLANTATION, 1992, 53 (03) : 580 - 582
  • [29] Tumor marker carcinoembryonic antigen,carbohydrate antigen 19-9 identifies loci and colorectal cancer risk
    Qian, Yun
    Wang, Lu
    Liu, Jia
    Shen, Qian
    Zhu, Meng
    CANCER SCIENCE, 2024, 115 : 952 - 952
  • [30] CA-50 AS A TUMOR-MARKER FOR MONITORING COLORECTAL-CANCER - ANTIGEN RISES IN PATIENTS POSTOPERATIVELY PRECEDE CLINICAL MANIFESTATIONS OF RECURRENCE
    PERSSON, BE
    STAHLE, E
    PAHLMAN, L
    GLIMELIUS, B
    HOLMGREN, J
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (02): : 241 - 246
12345